Clinical Trial Update: Expanded Natural Killer (NK) Cells for Multiple Myeloma Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study investigating expanded natural killer (NK) cells for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED